Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xpert Bladder Cancer Assay in BCG-treated NMIBC
NCT02895620Unknown
- Sponsor
- Institut Claudius Regaud
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut Claudius Regaud. Primary endpoint: Rate of negative Xpert tests results during the initiation course in patients with no recurrence at first follow-up cystoscopy at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT02895620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02895620.